NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers |
PAR-23-286 (K99/R00 - Independent Clinical Trial Not Allowed) |
R00, K99 |
Clinical Trial Not Allowed |
10/15/2026 |
Jessica Faupel-Badger, Ph.D., M.P.H. |
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research |
PAR-21-330 (U01 Clinical Trial Not Allowed) |
U01 |
Clinical Trial Not Allowed |
10/12/2024 |
Claire Zhu, Ph.D. |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research |
RFA-CA-24-009 (R33 Clinical Trial Not Allowed) |
R33 |
Clinical Trial Not Allowed |
10/02/2024 |
Guillermo Marquez, Ph.D. |
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research |
RFA-CA-24-008 (R61 Clinical Trial Not Allowed) |
R61 |
Clinical Trial Not Allowed |
10/02/2024 |
Guillermo Marquez, Ph.D. |
Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) |
NOT-OD-22-202 |
|
Clinical Trial Not Allowed |
04/16/2025 |
Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D. |
Mechanisms that Impact Cancer Risk after Bariatric Surgery |
PAR-21-332 (R21 Clinical Trial Not Allowed) |
R21 |
Clinical Trial Not Allowed |
09/08/2024 |
Edward Sauter, M.D., Ph.D. |
HEAL Initiative: Studies to Enable Analgesic Discovery |
RFA-NS-25-012 (R61/R33 - Clinical Trial Not Allowed) |
R61, R33 |
Clinical Trial Not Allowed |
01/16/2027 |
Rachel Altshuler, Ph.D. |
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment |
RFA-NS-22-034 (R01 Clinical Trial Not Allowed) |
R01 |
Clinical Trial Not Allowed |
12/07/2024 |
Rachel Altshuler, Ph.D. |
Discovery and Development of Natural Products for Cancer Interception and Prevention |
RFA-CA-23-028 (UG3/UH3 Clinical Trial Not Allowed) |
UH3, UG3 |
Clinical Trial Not Allowed |
06/14/2025 |
Altaf Mohammed, Ph.D. |
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer |
PAR-22-061 (R01 Clinical Trial Not Allowed) |
R01 |
Clinical Trial Not Allowed |
01/08/2025 |
Young Kim, Ph.D. |